Found 15 hits for monomerid = 3205 Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Protein kinase C alpha type
(Homo sapiens (Human)) | BDBM3205
((+/-)-anti-Methyl 2-[[2,6-dihydroxy-4-[[[2-(4-hydr...)Show SMILES COC(=O)c1cccc(O)c1C(=O)c1c(O)cc(cc1O)C(=O)O[C@@H]1CCC[C@H]1Cc1ccc(O)cc1 |r| Show InChI InChI=1S/C28H26O9/c1-36-28(35)19-5-3-6-20(30)24(19)26(33)25-21(31)13-17(14-22(25)32)27(34)37-23-7-2-4-16(23)12-15-8-10-18(29)11-9-15/h3,5-6,8-11,13-14,16,23,29-32H,2,4,7,12H2,1H3/t16-,23+/m0/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 1.40E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Sphinx Laboratories
| Assay Description PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs. |
J Med Chem 39: 5215-27 (1996)
Article DOI: 10.1021/jm960581w BindingDB Entry DOI: 10.7270/Q2G73BVV |
More data for this Ligand-Target Pair | |
PKC alpha and beta-2
(Homo sapiens (Human)) | BDBM3205
((+/-)-anti-Methyl 2-[[2,6-dihydroxy-4-[[[2-(4-hydr...)Show SMILES COC(=O)c1cccc(O)c1C(=O)c1c(O)cc(cc1O)C(=O)O[C@@H]1CCC[C@H]1Cc1ccc(O)cc1 |r| Show InChI InChI=1S/C28H26O9/c1-36-28(35)19-5-3-6-20(30)24(19)26(33)25-21(31)13-17(14-22(25)32)27(34)37-23-7-2-4-16(23)12-15-8-10-18(29)11-9-15/h3,5-6,8-11,13-14,16,23,29-32H,2,4,7,12H2,1H3/t16-,23+/m0/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article
| n/a | n/a | 100 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description Inhibition of protein kinase C beta II |
Bioorg Med Chem Lett 6: 1759-1764 (1996)
Article DOI: 10.1016/0960-894X(96)00311-3 BindingDB Entry DOI: 10.7270/Q2QR4X3R |
More data for this Ligand-Target Pair | |
PKC alpha and beta-2
(Homo sapiens (Human)) | BDBM3205
((+/-)-anti-Methyl 2-[[2,6-dihydroxy-4-[[[2-(4-hydr...)Show SMILES COC(=O)c1cccc(O)c1C(=O)c1c(O)cc(cc1O)C(=O)O[C@@H]1CCC[C@H]1Cc1ccc(O)cc1 |r| Show InChI InChI=1S/C28H26O9/c1-36-28(35)19-5-3-6-20(30)24(19)26(33)25-21(31)13-17(14-22(25)32)27(34)37-23-7-2-4-16(23)12-15-8-10-18(29)11-9-15/h3,5-6,8-11,13-14,16,23,29-32H,2,4,7,12H2,1H3/t16-,23+/m0/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 90 | n/a | n/a | n/a | n/a | n/a | n/a |
Sphinx Laboratories
| Assay Description PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs. |
J Med Chem 39: 5215-27 (1996)
Article DOI: 10.1021/jm960581w BindingDB Entry DOI: 10.7270/Q2G73BVV |
More data for this Ligand-Target Pair | |
Protein kinase C, gamma
(Homo sapiens (Human)) | BDBM3205
((+/-)-anti-Methyl 2-[[2,6-dihydroxy-4-[[[2-(4-hydr...)Show SMILES COC(=O)c1cccc(O)c1C(=O)c1c(O)cc(cc1O)C(=O)O[C@@H]1CCC[C@H]1Cc1ccc(O)cc1 |r| Show InChI InChI=1S/C28H26O9/c1-36-28(35)19-5-3-6-20(30)24(19)26(33)25-21(31)13-17(14-22(25)32)27(34)37-23-7-2-4-16(23)12-15-8-10-18(29)11-9-15/h3,5-6,8-11,13-14,16,23,29-32H,2,4,7,12H2,1H3/t16-,23+/m0/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 1.70E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Sphinx Laboratories
| Assay Description PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs. |
J Med Chem 39: 5215-27 (1996)
Article DOI: 10.1021/jm960581w BindingDB Entry DOI: 10.7270/Q2G73BVV |
More data for this Ligand-Target Pair | |
Protein kinase C delta type
(Homo sapiens (Human)) | BDBM3205
((+/-)-anti-Methyl 2-[[2,6-dihydroxy-4-[[[2-(4-hydr...)Show SMILES COC(=O)c1cccc(O)c1C(=O)c1c(O)cc(cc1O)C(=O)O[C@@H]1CCC[C@H]1Cc1ccc(O)cc1 |r| Show InChI InChI=1S/C28H26O9/c1-36-28(35)19-5-3-6-20(30)24(19)26(33)25-21(31)13-17(14-22(25)32)27(34)37-23-7-2-4-16(23)12-15-8-10-18(29)11-9-15/h3,5-6,8-11,13-14,16,23,29-32H,2,4,7,12H2,1H3/t16-,23+/m0/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 50 | n/a | n/a | n/a | n/a | n/a | n/a |
Sphinx Laboratories
| Assay Description PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs. |
J Med Chem 39: 5215-27 (1996)
Article DOI: 10.1021/jm960581w BindingDB Entry DOI: 10.7270/Q2G73BVV |
More data for this Ligand-Target Pair | |
Protein kinase C, epsilon
(Homo sapiens (Human)) | BDBM3205
((+/-)-anti-Methyl 2-[[2,6-dihydroxy-4-[[[2-(4-hydr...)Show SMILES COC(=O)c1cccc(O)c1C(=O)c1c(O)cc(cc1O)C(=O)O[C@@H]1CCC[C@H]1Cc1ccc(O)cc1 |r| Show InChI InChI=1S/C28H26O9/c1-36-28(35)19-5-3-6-20(30)24(19)26(33)25-21(31)13-17(14-22(25)32)27(34)37-23-7-2-4-16(23)12-15-8-10-18(29)11-9-15/h3,5-6,8-11,13-14,16,23,29-32H,2,4,7,12H2,1H3/t16-,23+/m0/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 4.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Sphinx Laboratories
| Assay Description PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs. |
J Med Chem 39: 5215-27 (1996)
Article DOI: 10.1021/jm960581w BindingDB Entry DOI: 10.7270/Q2G73BVV |
More data for this Ligand-Target Pair | |
Protein kinase C, eta
(Homo sapiens (Human)) | BDBM3205
((+/-)-anti-Methyl 2-[[2,6-dihydroxy-4-[[[2-(4-hydr...)Show SMILES COC(=O)c1cccc(O)c1C(=O)c1c(O)cc(cc1O)C(=O)O[C@@H]1CCC[C@H]1Cc1ccc(O)cc1 |r| Show InChI InChI=1S/C28H26O9/c1-36-28(35)19-5-3-6-20(30)24(19)26(33)25-21(31)13-17(14-22(25)32)27(34)37-23-7-2-4-16(23)12-15-8-10-18(29)11-9-15/h3,5-6,8-11,13-14,16,23,29-32H,2,4,7,12H2,1H3/t16-,23+/m0/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 40 | n/a | n/a | n/a | n/a | n/a | n/a |
Sphinx Laboratories
| Assay Description PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs. |
J Med Chem 39: 5215-27 (1996)
Article DOI: 10.1021/jm960581w BindingDB Entry DOI: 10.7270/Q2G73BVV |
More data for this Ligand-Target Pair | |
cAMP-Dependent Protein Kinase (PKA)
(Bos taurus (bovine)) | BDBM3205
((+/-)-anti-Methyl 2-[[2,6-dihydroxy-4-[[[2-(4-hydr...)Show SMILES COC(=O)c1cccc(O)c1C(=O)c1c(O)cc(cc1O)C(=O)O[C@@H]1CCC[C@H]1Cc1ccc(O)cc1 |r| Show InChI InChI=1S/C28H26O9/c1-36-28(35)19-5-3-6-20(30)24(19)26(33)25-21(31)13-17(14-22(25)32)27(34)37-23-7-2-4-16(23)12-15-8-10-18(29)11-9-15/h3,5-6,8-11,13-14,16,23,29-32H,2,4,7,12H2,1H3/t16-,23+/m0/s1 | PDB
UniProtKB/SwissProt
GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | >5.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Sphinx Laboratories
| Assay Description The activity of PKA, activated by cAMP, is measured by its ability to transfer phosphate from [gamma-32P]ATP to histone. |
J Med Chem 39: 5215-27 (1996)
Article DOI: 10.1021/jm960581w BindingDB Entry DOI: 10.7270/Q2G73BVV |
More data for this Ligand-Target Pair | |
Protein kinase C alpha type
(Homo sapiens (Human)) | BDBM3205
((+/-)-anti-Methyl 2-[[2,6-dihydroxy-4-[[[2-(4-hydr...)Show SMILES COC(=O)c1cccc(O)c1C(=O)c1c(O)cc(cc1O)C(=O)O[C@@H]1CCC[C@H]1Cc1ccc(O)cc1 |r| Show InChI InChI=1S/C28H26O9/c1-36-28(35)19-5-3-6-20(30)24(19)26(33)25-21(31)13-17(14-22(25)32)27(34)37-23-7-2-4-16(23)12-15-8-10-18(29)11-9-15/h3,5-6,8-11,13-14,16,23,29-32H,2,4,7,12H2,1H3/t16-,23+/m0/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article
| n/a | n/a | 1.40E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description Inhibition of protein kinase C alpha |
Bioorg Med Chem Lett 6: 1759-1764 (1996)
Article DOI: 10.1016/0960-894X(96)00311-3 BindingDB Entry DOI: 10.7270/Q2QR4X3R |
More data for this Ligand-Target Pair | |
Protein kinase C, eta
(Homo sapiens (Human)) | BDBM3205
((+/-)-anti-Methyl 2-[[2,6-dihydroxy-4-[[[2-(4-hydr...)Show SMILES COC(=O)c1cccc(O)c1C(=O)c1c(O)cc(cc1O)C(=O)O[C@@H]1CCC[C@H]1Cc1ccc(O)cc1 |r| Show InChI InChI=1S/C28H26O9/c1-36-28(35)19-5-3-6-20(30)24(19)26(33)25-21(31)13-17(14-22(25)32)27(34)37-23-7-2-4-16(23)12-15-8-10-18(29)11-9-15/h3,5-6,8-11,13-14,16,23,29-32H,2,4,7,12H2,1H3/t16-,23+/m0/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article
| n/a | n/a | 40 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description Inhibition of protein kinase C eta |
Bioorg Med Chem Lett 6: 1759-1764 (1996)
Article DOI: 10.1016/0960-894X(96)00311-3 BindingDB Entry DOI: 10.7270/Q2QR4X3R |
More data for this Ligand-Target Pair | |
PKC alpha and beta-2
(Homo sapiens (Human)) | BDBM3205
((+/-)-anti-Methyl 2-[[2,6-dihydroxy-4-[[[2-(4-hydr...)Show SMILES COC(=O)c1cccc(O)c1C(=O)c1c(O)cc(cc1O)C(=O)O[C@@H]1CCC[C@H]1Cc1ccc(O)cc1 |r| Show InChI InChI=1S/C28H26O9/c1-36-28(35)19-5-3-6-20(30)24(19)26(33)25-21(31)13-17(14-22(25)32)27(34)37-23-7-2-4-16(23)12-15-8-10-18(29)11-9-15/h3,5-6,8-11,13-14,16,23,29-32H,2,4,7,12H2,1H3/t16-,23+/m0/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article
| n/a | n/a | 90 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description Inhibition of protein kinase C beta II |
Bioorg Med Chem Lett 6: 1759-1764 (1996)
Article DOI: 10.1016/0960-894X(96)00311-3 BindingDB Entry DOI: 10.7270/Q2QR4X3R |
More data for this Ligand-Target Pair | |
Protein kinase C delta type
(Homo sapiens (Human)) | BDBM3205
((+/-)-anti-Methyl 2-[[2,6-dihydroxy-4-[[[2-(4-hydr...)Show SMILES COC(=O)c1cccc(O)c1C(=O)c1c(O)cc(cc1O)C(=O)O[C@@H]1CCC[C@H]1Cc1ccc(O)cc1 |r| Show InChI InChI=1S/C28H26O9/c1-36-28(35)19-5-3-6-20(30)24(19)26(33)25-21(31)13-17(14-22(25)32)27(34)37-23-7-2-4-16(23)12-15-8-10-18(29)11-9-15/h3,5-6,8-11,13-14,16,23,29-32H,2,4,7,12H2,1H3/t16-,23+/m0/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article
| n/a | n/a | 50 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description Inhibition of protein kinase C delta |
Bioorg Med Chem Lett 6: 1759-1764 (1996)
Article DOI: 10.1016/0960-894X(96)00311-3 BindingDB Entry DOI: 10.7270/Q2QR4X3R |
More data for this Ligand-Target Pair | |
Protein kinase C, gamma
(Homo sapiens (Human)) | BDBM3205
((+/-)-anti-Methyl 2-[[2,6-dihydroxy-4-[[[2-(4-hydr...)Show SMILES COC(=O)c1cccc(O)c1C(=O)c1c(O)cc(cc1O)C(=O)O[C@@H]1CCC[C@H]1Cc1ccc(O)cc1 |r| Show InChI InChI=1S/C28H26O9/c1-36-28(35)19-5-3-6-20(30)24(19)26(33)25-21(31)13-17(14-22(25)32)27(34)37-23-7-2-4-16(23)12-15-8-10-18(29)11-9-15/h3,5-6,8-11,13-14,16,23,29-32H,2,4,7,12H2,1H3/t16-,23+/m0/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article
| n/a | n/a | 1.70E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description Inhibition of protein kinase C gamma |
Bioorg Med Chem Lett 6: 1759-1764 (1996)
Article DOI: 10.1016/0960-894X(96)00311-3 BindingDB Entry DOI: 10.7270/Q2QR4X3R |
More data for this Ligand-Target Pair | |
Protein kinase C, epsilon
(Homo sapiens (Human)) | BDBM3205
((+/-)-anti-Methyl 2-[[2,6-dihydroxy-4-[[[2-(4-hydr...)Show SMILES COC(=O)c1cccc(O)c1C(=O)c1c(O)cc(cc1O)C(=O)O[C@@H]1CCC[C@H]1Cc1ccc(O)cc1 |r| Show InChI InChI=1S/C28H26O9/c1-36-28(35)19-5-3-6-20(30)24(19)26(33)25-21(31)13-17(14-22(25)32)27(34)37-23-7-2-4-16(23)12-15-8-10-18(29)11-9-15/h3,5-6,8-11,13-14,16,23,29-32H,2,4,7,12H2,1H3/t16-,23+/m0/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article
| n/a | n/a | 4.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description Inhibition of protein kinase C epsilon |
Bioorg Med Chem Lett 6: 1759-1764 (1996)
Article DOI: 10.1016/0960-894X(96)00311-3 BindingDB Entry DOI: 10.7270/Q2QR4X3R |
More data for this Ligand-Target Pair | |
PKC alpha and beta-2
(Homo sapiens (Human)) | BDBM3205
((+/-)-anti-Methyl 2-[[2,6-dihydroxy-4-[[[2-(4-hydr...)Show SMILES COC(=O)c1cccc(O)c1C(=O)c1c(O)cc(cc1O)C(=O)O[C@@H]1CCC[C@H]1Cc1ccc(O)cc1 |r| Show InChI InChI=1S/C28H26O9/c1-36-28(35)19-5-3-6-20(30)24(19)26(33)25-21(31)13-17(14-22(25)32)27(34)37-23-7-2-4-16(23)12-15-8-10-18(29)11-9-15/h3,5-6,8-11,13-14,16,23,29-32H,2,4,7,12H2,1H3/t16-,23+/m0/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 100 | n/a | n/a | n/a | n/a | n/a | n/a |
Sphinx Laboratories
| Assay Description PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs. |
J Med Chem 39: 5215-27 (1996)
Article DOI: 10.1021/jm960581w BindingDB Entry DOI: 10.7270/Q2G73BVV |
More data for this Ligand-Target Pair | |